Skip to main navigation Skip to search Skip to main content

Strategy for rational combinations of therapeutics to target resistant human myeloma cell lines. Collaborative Agreement Celgene and Prof Andrew Spencer and Dr Tiffany Khong.

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Khong, Tiffany (Chief Investigator (CI))
  • Plowman, Chris (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date2/10/19 → 31/12/24

Keywords

  • Malignant Haematology